Dual Targeting of Insulin and Venus Kinase Receptors of Schistosoma mansoni for Novel Anti-schistosome Therapy

PLoS Neglected Tropical Diseases

Volumn 7, Issue 5, 2013, Pages

  Vanderstraete, Mathieu ^a   Gouignard, Nadège ^a   Cailliau, Katia ^a   Morel, Marion ^a   Lancelot, Julien ^a   Bodart, Jean François ^a   Dissous, Colette ^a  

^a UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 BROMO 5 TERT BUTYL 4 HYDROXYBENZYLIDENEMALONONITRILE; 4 (3 CHLOROANILINO) 6, 7 DIMETHOXYQUINAZOLINE; INSULIN RECEPTOR; N (3 CHLOROPHENYL) 3 [3, 5 DIMETHYL 4 (4 METHYL 1 PIPERAZINYLCARBONYL) 1H PYRROL 2 YLMETHYLENE] 2, 3 DIHYDRO N METHYL 2 OXO 1H INDOLE 5 SULFONAMIDE; NINTEDANIB; RECEPTOR; UNCLASSIFIED DRUG; VENUS KINASE RECEPTOR;

APOPTOSIS; ARTICLE; CELL DEATH; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG TARGETING; FEMALE; FERTILITY; GROWTH INHIBITION; IMMUNOPRECIPITATION; MALE; MEIOSIS; MOLECULAR CLONING; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; SCHISTOSOMA MANSONI; WESTERN BLOTTING; XENOPUS;

EID: 84878486356     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002226     Document Type: Article

References (41)

1. Steinmann P, Keiser J, Tanner M, Utzinger J, (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6: 411-425.
2. Gryseels B, Polman K, Clerinx J, Kestens L, (2006) Human schistosomiasis. Lancet 368: 1106-1118.
3. Fenwick A, Webster JP, (2006) Schistosomiasis: challenges for control, treatment and drug resistance. Curr Opin Infect Dis 19: 577-582.
4. Doenhoff MJ, Pica-Mattocia L, (2006) Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. Exp Rev Anti Infect Ther 4: 199-210.
5. DeMarco R, Verjovski-Almeida S, (2009) Schistosomes-proteomics studies for potential novel vaccines and drug targets. Drug Discov Today 14: 472-478.
6. Dissous C, Khayath N, Vicogne J, Capron M, (2006) Growth factor receptors in helminth parasites: signalling and host-parasite relationships. Febs Lett FEBS Lett 580: 2968-2975.
7. Dissous C, Ahier A, Khayath N, (2007) Protein tyrosine kinases as new potential targets against human schistosomiasis. Bioessays 29: 1281-1288.
8. Dissous C, Grevelding CG, (2011) Piggy-backing the concept of cancer drugs for schistosomiasis treatment: a tangible perspective? Trends Parasitol 27: 59-66.
9. Hubbard SR, Till JF, (2000) Protein tyrosine kinase structure and function. Annu Rev Biochem 69: 373-398.
10. Harris CA, Ward RL, Dobbins TA, Drew AK, Pearson S, (2011) The efficacy of HER2-targeted agents in metastatic breast cancer: a meta-analysis. Ann Oncol 22: 1308-1317.
11. Gronchi A, Blay JY, Trent JC, (2010) The role of high-dose imatinib in the management of patients with gastrointestinal stromal tumor. Cancer 116: 1847-1858.
12. Wagner AD, Arnold D, Grothey AA, Haerting J, Unverzagt S, (2009) Anti-angiogenic therapies for metastatic colorectal cancer. Cochrane Database Syst Rev 8 (3):: CD005392.
13. LeRoith D, Roberts CT Jr, (2003) The insulin-like growth factor system and cancer. Cancer Lett 195: 127-137.
14. Reinmuth N, Fan F, Liu W, Parikh AA, Stoeltzing O, et al. (2002) Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer. Lab Invest 82: 1377-1389.
15. Buck E, Gokhale PC, Koujak S, Brown E, Eyzaguirre A, et al. (2010) Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer. Mol Cancer Ther 9: 2652-2664.
16. Schäcke H, Schröder HC, Gamulin V, Rinkevich B, Müller IM, et al. (1994) Molecular cloning of a tyrosine kinase gene from the marine sponge Geodia cydonium: a new member belonging to the receptor tyrosine kinase class II family. Mol Membr Biol 11: 101-107.
17. Khayath N, Vicogne J, Ahier A, BenYounes A, Konrad C, et al. (2007) Diversification of the insulin receptor family in the helminth parasite Schistosoma mansoni. FEBS J 274: 659-676.
18. Skelly PJ, Kim JW, Cunningham J, Shoemaker CB, (1994) Cloning, characterization and functional expression of cDNAs encoding glucose transporter proteins from the human parasite Schistosoma mansoni. J Biol Chem 269: 4247-4253.
19. You H, Zhang W, Jones MK, Gobert GN, Mulvenna J, et al. (2010) Cloning and characterisation of Schistosoma japonicum insulin receptors. PLoS One 5 (3):: e9868.
20. Ahier A, Khayath N, Vicogne J, Dissous C, (2008) Insulin receptors and glucose uptake in the human parasite Schistosoma mansoni. Parasite 4: 573-579.
21. Vicogne J, Pin JP, Lardans V, Capron M, Noël C, et al. (2003) An unusual receptor tyrosine kinase of Schistosoma mansoni contains a Venus Flytrap module. Mol Biochem Parasitol 126: 51-62.
22. Ahier A, Rondard P, Gouignard N, Khayath N, Huang S, et al. (2009) A new family of receptor tyrosine kinases with a venus flytrap binding domain in insects and other invertebrates activated by aminoacids. PLoS One 4 (5):: e5651.
23. Gouignard N, Vanderstraete M, Cailliau K, Lescuyer A, Browaeys E, et al. (2012) Schistosoma mansoni: structural and biochemical characterization of two distinct Venus Kinase Receptors. Exp Parasitol 132: 32-39.
24. Dissous C, Dissous C, Capron A, (1981) Isolation and characterization of surface antigens from Schistosoma mansoni schistosomula. Mol Biochem Parasitol 3: 215-225.
25. Vicogne J, Cailliau K, Tulasne D, Browaeys E, Yan YT, et al. (2004) Conservation of epidermal growth factor receptor function in the human parasitic helminth Schistosoma mansoni. J Biol Chem 279: 37407-37414.
26. Machado-Silva JR, Pelajo-Machado M, Lenzi HL, Gomes DC, (1998) Morphological study of adult male worms of Schistosoma mansoni Sambon, 1907 by confocal laser scanning microscopy. Mem Inst Oswaldo Cruz 93 Suppl 1: 303-307.
27. Neves RH, de Lamare Biolchini C, Machado-Silva JR, Carvalho JJ, Branquinho TB, et al. (2005) A new description of the reproductive system of Schistosoma mansoni (Trematoda: Schistosomatidae) analyzed by confocal laser scanning microscopy. Parasitol Res 95: 43-49.
28. Yan Y, Tulasne D, Browaeys E, Cailliau K, Khayath N, et al. (2007) Molecular cloning and characterisation of SmSLK, a novel Ste20-like kinase in Schistosoma mansoni. Int J Parasitol 37: 1539-1550.
29. Long T, Cailliau K, Beckmann S, Browaeys E, Trolet J, et al. (2010) Schistosoma mansoni Polo-like kinase 1: A mitotic kinase with key functions in parasite reproduction. Int J Parasitol 40: 1075-1086.
30. Long T, Vanderstraete M, Cailliau K, Morel M, Lescuyer A, et al. (2012) SmSak, the second Polo-like kinase of the helminth parasite Schistosoma mansoni: conserved and unexpected roles in meiosis. PloS One 7 (6):: e40045.
31. Beckmann S, Buro C, Dissous C, Hirzmann J, Grevelding CG, (2010) The Syk kinase SmTK4 of Schistosoma mansoni is involved in the regulation of spermatogenesis and oogenesis. PLoS Pathog 6 (2):: e1000769.
32. Beckmann S, Hahnel S, Cailliau K, Vanderstraete M, Browaeys E, et al. (2011) Characterization of the Src/Abl hybrid kinase SmTK6 of Schistosoma mansoni. J Biol Chem 286: 42325-42336.
33. Wen B, Deutsch E, Marangoni E, Frascona V, Maggiorella L, et al. (2001) Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells. Br J Cancer 85 (12):: 2017-2021.
34. Knobloch J, Kunz W, Grevelding CG, (2006) Herbimycin A suppresses mitotic activity and egg production of female Schistosoma mansoni. Int J Parasitol 36: 1261-1272.
35. Beckmann S, Grevelding CG, (2010) Imatinib has a fatal impact on morphology, pairing stability and survival of adult Schistosoma mansoni in vitro. Int J Parasitol 40: 521-526.
36. Wang X, Chen W, Huang Y, Sun J, Men J, et al. (2011) The draft genome of the carcinogenic human liver fluke Clonorchis sinensis. Genome Biol 12 (10):: R107.
37. Parrizas M, Gazit A, Levitzki A, Wertheimer E, LeRoith D, (1997) Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinology 138: 1427-1433.
38. Blum G, Gazit A, Levitzki A, (2000) Substrate competitive inhibitors of IGF-1 receptor kinase. Biochemistry 39: 15705-15712.
39. Saperstein R, Vicario PP, Strout HV, Brady E, Slater EE, et al. (1989) Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cells. Biochemistry 28: 5694-5701.
40. You H, Gobert GN, Duke MG, Zhang W, Li Y, et al. (2012) The insulin receptor is a transmission blocking veterinary vaccine target for zoonotic Schistosoma japonicum. Int J Parasitol 42: 801-807.
41. Von Willebrand M, Zacksenhaus E, Cheng E, Glazer P, Halaban R, (2003) The tyrphostin AG1024 accelerates the degradation of phosphorylated forms of Retinoblastoma Protein (pRb) and restores pRb tumor suppressive function in melanoma cells. Cancer Res 63: 1420-1429.